Brains Bioceutical Corp
SPEAKER
MEDICINE
Pioneering Breakthrough Cannabinoid Treatments in Areas of High Unmet Need
"Pioneering breakthrough cannabinoid treatments in areas of high unmet need," Brains Bioceutical Corp President Terry O'Regan will address some of the strategies to overcome challenges of conducting successful cannabinoid clinical trials and optimize the potential for success. Despite the wide range of therapeutic targets, the industry has yet to prove the full potential of these molecules as breakthrough treatments for devastating diseases. Mr. O'Regan will present data from a pioneering preclinical study using a cannabidiol-based nano formulation, which shows benefits above the current standard of care to reduce tumor burden and prolong survival in cancer treatments.
In order for these discoveries to be translated into effective treatments for patients, it is essential that proper due diligence is done, and well-designed clinical trials programs are initiated. In this presentation, we will discuss the course, challenges, considerations, and rewards for advancing the cannabinoid scientific research.
BIO
Terry O’Regan is an experienced leader and strategist with a proven track record of exceeding ambitious performance goals in the USA, Europe and International. He has successfully led large teams, launched several market leaders, returned mature businesses back to growth, successfully negotiated the reimbursement of products, built franchises, defended against generic erosion of a major brand and negotiated the approval of a rare disease treatment for its full licensed indication on the NHS.
Former elected Chairperson of the ‘American Pharmaceutical Group’ to raise the profile and reputation of the Pharma-Biotech industry in the UK, including influencing Government Policy within the Life Science sector.
View CannMed Resources Below:
ATTENDANCE IS LIMITED. THE OPPORTUNITIES ARE NOT.
